UPDATE: Section 122 tariff (10%) in effect since Feb 24 — expires ~July 24 (~126 days). 24 states challenge in court (March 5). USTR launches new Section 301 probes (March 11). EU trade deal vote imminent. Full analysis →

HTS 3004 — Medicaments in dosage form Tariff Rate (2026)

Medicaments in measured doses or packaged for retail sale. The largest pharmaceutical import category by value.

Duty Rates

Free

MFN Rate

10%

Section 122

N/A

Section 232

N/A

Section 301 (China)

Top Countries of Origin

Products classified under HTS 3004 — Medicaments in dosage form — are among the globally sourced imports entering the US. Medicaments in measured doses or packaged for retail sale. The largest pharmaceutical import category by value. All imports under this heading are subject to the 10% Section 122 tariff (effective February 24, 2026). The top countries of origin for HTS 3004 imports include IE, DE, CH, IN, IL. Tariff rates vary by source country based on applicable trade agreements and special tariff programs.

Frequently Asked Questions

What is the tariff rate for HTS 3004 (Medicaments in dosage form)?

The MFN duty rate for HTS 3004 is Free. All imports also face the 10% Section 122 tariff.

Where do most HTS 3004 imports come from?

The top origin countries for medicaments in dosage form are IE, DE, CH, IN, IL. Tariff rates vary based on the source country's trade agreements and applicable surcharges.

Will the tariff on HTS 3004 change in 2026?

The 10% Section 122 tariff expires approximately July 24, 2026 unless Congress acts. MFN rates and Section 232/301 tariffs have no set expiration. Monitor legislative and executive actions for changes.